Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimosiamose 5% Cream in Chronic Plaque Type Psoriasis
NCT00823693Phase 2Completed
- Sponsor
- Revotar Biopharmaceuticals
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bimosiamose in plaque psoriasis, sponsored by Revotar Biopharmaceuticals. Status: completed.
02
Drugs
bimosiamose
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00823693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00823693.